iDexis Semaglutide Ban Ordered By High Court

iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.

Compounded GLP-1 Injections Spark Regulatory Battle

Compounded GLP-1 injections are at the centre of a regulatory dispute. iDexis challenges SAHPRA and SAPC recall orders.